ctrl K

Price Alert

Dianthus Therapeutics Inc... (DNTH)

NASDAQ: DNTH · Real-Time Price · USD

20.71

0.46 (2.27%)

At close: Aug 15, 2025, 3:59 PM

20.74

0.14%

After-hours: Aug 15, 2025, 04:10 PM EDT

Dianthus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	22.79M	132.32M	15.37M	7.64M
Short-Term Investments	252.45M	41.39M	60.13M	45.28M
Long-Term Investments	81.73M	66K	60K	1.78M
Other Long-Term Assets	9.63M	1.09M	61K	-1.75M
Receivables	807K	478K	5.64M	1.48M
Inventory	n/a	n/a	852K	n/a
Other Current Assets	355K	2.66M	21K	-169.28M
Total Current Assets	280.9M	177.45M	82.03M	9.39M
Property-Plant & Equipment	1.75M	800K	956K	33K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	93.1M	1.95M	1.08M	63K
Total Assets	374.01M	179.41M	83.11M	9.45M
Account Payables	4.58M	2.61M	1.17M	1.36M
Deferred Revenue	479K	100K	100K	n/a
Short-Term Debt	320K	417K	350K	n/a
Other Current Liabilities	13.07M	4.94M	4.17M	207K
Total Current Liabilities	18.45M	9.63M	8.22M	5.35M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	21.35M
Total Long-Term Liabilities	3.08M	904K	1.23M	21.35M
Total Liabilities	21.53M	10.54M	127.48M	26.7M
Total Debt	1.49M	585K	788K	n/a
Common Stock	31K	15K	61K	59K
Retained Earnings	-174.39M	-89.42M	-45.87M	-325.57M
Comprehensive Income	106K	47K	-161K	-30K
Shareholders Equity	352.48M	168.87M	-44.37M	172.67M
Total Investments	334.18M	41.46M	60.13M	47.06M